Abstract Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1DeltaE or N3DeltaE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
AbstractList Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. Results RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1[DELTA]E or N3[DELTA]E), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). Conclusion The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1[DELTA]E or N3[DELTA]E), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
Abstract Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. Results RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1ΔE or N3ΔE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). Conclusion The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
Abstract Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. Results RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1ΔE or N3ΔE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). Conclusion The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
BACKGROUND: Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. RESULTS: RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1ΔE or N3ΔE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). CONCLUSION: The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
BACKGROUNDDysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. RESULTSRNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1DeltaE or N3DeltaE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). CONCLUSIONThe identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch signalling promotes proliferation and inhibits apoptosis of T cell acute lymphoblastic leukaemia (T-ALL) cells. In this study we aimed to identify novel transcriptional targets of Notch signalling in the T-ALL cell line, Jurkat. RNA was prepared from Jurkat cells retrovirally transduced with an empty vector (GFP-alone) or vectors containing constitutively active forms of Notch (N1DeltaE or N3DeltaE), and used for Affymetrix microarray analysis. A subset of genes found to be regulated by Notch was chosen for real-time PCR validation and in some cases, validation at the protein level, using several Notch-transduced T-ALL and non-T-ALL leukaemic cell lines. As expected, several known transcriptional target of Notch, such as HES1 and Deltex, were found to be overexpressed in Notch-transduced cells, however, many novel transcriptional targets of Notch signalling were identified using this approach. These included the T cell costimulatory molecule CD28, the anti-apoptotic protein GIMAP5, and inhibitor of DNA binding 1 (1D1). The identification of such downstream Notch target genes provides insights into the mechanisms of Notch function in T cell leukaemia, and may help identify novel therapeutic targets in this disease.
ArticleNumber 35
Audience Academic
Author Zeef, Leo
Warrander, Fiona
Hoyle, Sarah
Fennessy, Carl
Chadwick, Nicholas
Portillo, Virginia
Buckle, Anne-Marie
AuthorAffiliation 1 Faculty of Life Sciences, Manchester Interdisciplinary Biocenter, University of Manchester, Manchester M1 7DN, UK
2 Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M1 7DN, UK
AuthorAffiliation_xml – name: 2 Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M1 7DN, UK
– name: 1 Faculty of Life Sciences, Manchester Interdisciplinary Biocenter, University of Manchester, Manchester M1 7DN, UK
Author_xml – sequence: 1
  givenname: Nicholas
  surname: Chadwick
  fullname: Chadwick, Nicholas
  email: n.chadwick@manchester.ac.uk
  organization: Faculty of Life Sciences, Manchester Interdisciplinary Biocenter, University of Manchester, Manchester, UK. n.chadwick@manchester.ac.uk
– sequence: 2
  givenname: Leo
  surname: Zeef
  fullname: Zeef, Leo
– sequence: 3
  givenname: Virginia
  surname: Portillo
  fullname: Portillo, Virginia
– sequence: 4
  givenname: Carl
  surname: Fennessy
  fullname: Fennessy, Carl
– sequence: 5
  givenname: Fiona
  surname: Warrander
  fullname: Warrander, Fiona
– sequence: 6
  givenname: Sarah
  surname: Hoyle
  fullname: Hoyle, Sarah
– sequence: 7
  givenname: Anne-Marie
  surname: Buckle
  fullname: Buckle, Anne-Marie
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19508709$$D View this record in MEDLINE/PubMed
BookMark eNp1kstr3DAQh0VJaF699lgMhd6cStbo4UtgCX0shOaSnIUsjxyltpTa3kD--8rdJc3SlDlImvnpY14n5CCmiIS8Z_ScMS0_M1CyBFHrUpdcvCHHz46DF_cjcjJN95QypRW8JUesFlQrWh-Ti3WLcQ4-ODuHFIvki5gesS9-pNndFbMdO5yLDiNORYjFTeGw74seNz8tDsGekUNv-wnf7c5Tcvv1y83l9_Lq-tv6cnVVNkLVc6kZAHWC5ZdTNWjvAdBTVMA5tgK0haoS4HkLbeNQVt7a2teaKfQVo8BPyXrLbZO9Nw9jGOz4ZJIN5o8jjZ2x4xxcjwaYk1xSKxkiQCXqRlXQgnRCcsaFy6yLLeth0wzYulz_aPs96H4khjvTpUdTyVprkBmw2gKakP4D2I-4NJhlFmaZhdGGi8z4tEtiTL82OM1mCNPSWxsxbSYjFVCmGcvCj1thZ3NxIfqUkW4Rm1VFs4k8yKw6f0WVrc1TcnllfMj-1z64MU3TiP45fUbNsln_JvzhZdf-ynerxH8DYT7I1A
CitedBy_id crossref_primary_10_3389_fimmu_2021_679739
crossref_primary_10_1182_blood_2009_08_237586
crossref_primary_10_1210_me_2013_1425
crossref_primary_10_1016_j_str_2013_01_014
crossref_primary_10_1038_leu_2016_392
crossref_primary_10_1002_path_2895
crossref_primary_10_1111_febs_16815
crossref_primary_10_3389_fcell_2023_1231416
crossref_primary_10_3892_ol_2013_1523
crossref_primary_10_1242_jcs_154583
crossref_primary_10_1371_journal_pone_0100359
crossref_primary_10_1182_blood_2017_11_742577
crossref_primary_10_1074_jbc_M113_519405
crossref_primary_10_3389_fonc_2019_00198
crossref_primary_10_1155_2013_348212
crossref_primary_10_1242_dev_063610
crossref_primary_10_2298_AOO0904072M
crossref_primary_10_1038_nrc3638
crossref_primary_10_1080_10428194_2016_1180681
crossref_primary_10_1038_aps_2015_42
crossref_primary_10_1038_emboj_2012_129
crossref_primary_10_1155_2015_750203
crossref_primary_10_4049_jimmunol_1501582
crossref_primary_10_1371_journal_pone_0024937
crossref_primary_10_1007_s11033_013_2654_8
crossref_primary_10_1016_j_canlet_2011_05_009
crossref_primary_10_1016_j_canlet_2011_02_034
crossref_primary_10_1016_j_jmb_2014_12_012
crossref_primary_10_1101_gad_176834_111
crossref_primary_10_3390_cancers15030671
crossref_primary_10_3390_ijms25105130
crossref_primary_10_1038_icb_2010_57
crossref_primary_10_1053_j_seminoncol_2017_06_005
crossref_primary_10_1038_leu_2012_285
crossref_primary_10_1177_0300060513485912
crossref_primary_10_1158_0008_5472_CAN_13_2022
crossref_primary_10_1073_pnas_1109023108
crossref_primary_10_1016_j_bcmd_2010_07_006
crossref_primary_10_1371_journal_pone_0123016
crossref_primary_10_1016_j_cell_2014_09_051
crossref_primary_10_1155_2010_268589
crossref_primary_10_1186_1471_2407_13_176
crossref_primary_10_1007_s12539_019_00325_y
crossref_primary_10_3390_biomedicines11010230
crossref_primary_10_1016_j_gene_2014_12_054
crossref_primary_10_1042_BSR20171255
crossref_primary_10_1002_dvdy_24439
Cites_doi 10.1038/sj.emboj.7600902
10.1002/eji.200526279
10.1038/377355a0
10.4049/jimmunol.177.9.6098
10.1016/j.smim.2005.01.004
10.1038/sj.embor.7400013
10.1371/journal.pbio.0040103
10.1093/emboj/19.13.3337
10.1006/bbrc.2000.3458
10.1074/jbc.M506108200
10.1093/bioinformatics/19.2.185
10.1128/MCB.23.2.655-664.2003
10.1038/ni1160
10.4049/jimmunol.166.5.3468
10.1006/bbrc.2002.6528
10.1016/j.chembiol.2006.12.010
10.1084/jem.183.5.2283
10.1128/MCB.01091-06
10.1016/S1535-6108(03)00141-7
10.1073/pnas.0606108103
10.1126/science.1102160
10.1016/S1074-7613(00)80643-3
10.1101/gad.1450406
10.1073/pnas.062050599
10.1016/j.bbrc.2007.07.048
10.1158/0008-5472.CAN-05-3830
10.1016/j.bbrc.2006.04.097
10.1046/j.1365-2567.2000.00110.x
10.1016/S0171-2985(97)80050-2
10.1002/eji.200535791
10.1038/nri1349
10.1128/MCB.21.17.6071-6079.2001
10.1073/pnas.0806445106
10.4049/jimmunol.171.9.4504
10.1634/stemcells.2007-0368
10.1038/nm1636
10.1128/MCB.18.12.7423
10.1210/me.2003-0390
10.1126/science.1074560
10.1073/pnas.1832170100
10.1038/sj.leu.2404258
10.1073/pnas.98.1.31
10.1093/bioinformatics/17.6.509
10.1016/0092-8674(91)90111-B
10.1073/pnas.1530509100
10.1182/blood-2007-12-130096
ContentType Journal Article
Copyright COPYRIGHT 2009 BioMed Central Ltd.
Copyright © 2009 Chadwick et al; licensee BioMed Central Ltd. 2009 Chadwick et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2009 BioMed Central Ltd.
– notice: Copyright © 2009 Chadwick et al; licensee BioMed Central Ltd. 2009 Chadwick et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1186/1476-4598-8-35
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList


CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-4598
EndPage 35
ExternalDocumentID oai_doaj_org_article_41c6360a61ee44259b724d46c563135c
oai_biomedcentral_com_1476_4598_8_35
A202025870
10_1186_1476_4598_8_35
19508709
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
GeographicLocations_xml – name: United Kingdom
GroupedDBID ---
-A0
0R~
123
29M
2VQ
2WC
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
H13
HH5
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PZZ
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
AFGXO
7X8
ABVAZ
AFNRJ
5PM
ID FETCH-LOGICAL-b579t-81440c51b57c7948ff44ef0e7433ed548a42254f3d4dbce62faa9f9817ef21043
IEDL.DBID RPM
ISSN 1476-4598
IngestDate Thu Sep 05 15:36:37 EDT 2024
Tue Sep 17 20:40:34 EDT 2024
Wed May 22 07:12:34 EDT 2024
Sat Aug 17 01:15:22 EDT 2024
Wed Jul 24 18:22:44 EDT 2024
Tue Jul 23 04:31:45 EDT 2024
Thu Sep 12 20:00:14 EDT 2024
Sat Sep 28 07:53:34 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 35
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b579t-81440c51b57c7948ff44ef0e7433ed548a42254f3d4dbce62faa9f9817ef21043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698846/
PMID 19508709
PQID 67401811
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_41c6360a61ee44259b724d46c563135c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2698846
biomedcentral_primary_oai_biomedcentral_com_1476_4598_8_35
proquest_miscellaneous_67401811
gale_infotracmisc_A202025870
gale_infotracacademiconefile_A202025870
crossref_primary_10_1186_1476_4598_8_35
pubmed_primary_19508709
PublicationCentury 2000
PublicationDate 2009-06-09
PublicationDateYYYYMMDD 2009-06-09
PublicationDate_xml – month: 06
  year: 2009
  text: 2009-06-09
  day: 09
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Molecular cancer
PublicationTitleAlternate Mol Cancer
PublicationYear 2009
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 14566327 - EMBO Rep. 2003 Nov;4(11):1067-72
15122199 - Nat Rev Immunol. 2004 May;4(5):336-47
15472075 - Science. 2004 Oct 8;306(5694):269-71
9881968 - Immunity. 1998 Dec;9(6):777-86
16651424 - Cancer Res. 2006 May 1;66(9):4715-24
17114293 - Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18261-6
14568923 - J Immunol. 2003 Nov 1;171(9):4504-11
8642337 - J Exp Med. 1996 May 1;183(5):2283-91
11106933 - Immunology. 2000 Nov;101(3):309-15
14701943 - Mol Endocrinol. 2004 Mar;18(3):687-95
11395427 - Bioinformatics. 2001 Jun;17(6):509-19
16319921 - EMBO J. 2006 Jan 11;25(1):129-38
17873882 - Nat Med. 2007 Oct;13(10):1203-10
19118200 - Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):244-9
11724283 - Anticancer Res. 2001 Jul-Aug;21(4A):2281-6
16688224 - Leukemia. 2006 Jul;20(7):1279-87
17056536 - J Immunol. 2006 Nov 1;177(9):6098-107
7566092 - Nature. 1995 Sep 28;377(6547):355-8
11486044 - Mol Cell Biol. 2001 Sep;21(17):6071-9
10880446 - EMBO J. 2000 Jul 3;19(13):3337-48
18411416 - Blood. 2008 Aug 1;112(3):733-40
16682003 - Biochem Biophys Res Commun. 2006 Jun 23;345(1):446-52
17655828 - Biochem Biophys Res Commun. 2007 Sep 21;361(2):481-6
12883005 - Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5
15640801 - Nat Immunol. 2005 Feb;6(2):152-62
16509771 - PLoS Biol. 2006 Apr;4(4):e103
11207305 - J Immunol. 2001 Mar 1;166(5):3468-75
17317574 - Chem Biol. 2007 Feb;14(2):209-19
12509463 - Mol Cell Biol. 2003 Jan;23(2):655-64
12930893 - Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10382-7
11891328 - Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3788-93
11134512 - Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
16847353 - Genes Dev. 2006 Aug 1;20(15):2096-109
9442401 - Immunobiology. 1997 Dec;198(1-3):299-306
1831692 - Cell. 1991 Aug 23;66(4):649-61
9819428 - Mol Cell Biol. 1998 Dec;18(12):7423-31
16224812 - Eur J Immunol. 2005 Nov;35(11):3287-96
11866432 - Biochem Biophys Res Commun. 2002 Mar 8;291(4):775-9
16838279 - Eur J Immunol. 2006 Aug;36(8):2223-34
12399594 - Science. 2002 Oct 25;298(5594):840-3
16365048 - J Biol Chem. 2006 Feb 24;281(8):5106-19
12842081 - Cancer Cell. 2003 Jun;3(6):525-30
16954387 - Mol Cell Biol. 2006 Nov;26(21):8022-31
12538238 - Bioinformatics. 2003 Jan 22;19(2):185-93
18055449 - Stem Cells. 2008 Mar;26(3):715-23
11006105 - Biochem Biophys Res Commun. 2000 Sep 16;276(1):189-96
7545086 - Cancer Res. 1995 Sep 15;55(18):4140-5
15737573 - Semin Immunol. 2005 Apr;17(2):121-7
JD Storey (420_CR19) 2003; 100
LJ Strobl (420_CR20) 1997; 198
DJ McKean (420_CR48) 2001; 166
CT Ong (420_CR22) 2006; 281
L Chen (420_CR25) 2004; 4
H Hirata (420_CR34) 2002; 298
VM Sharma (420_CR39) 2006; 26
K Shimizu (420_CR21) 2002; 291
LW Ellisen (420_CR1) 1991; 66
M Keita (420_CR37) 2007; 361
X Tai (420_CR46) 2005; 6
S Jarriault (420_CR23) 1998; 18
J van den Brandt (420_CR30) 2004; 18
M Erlacher (420_CR27) 2005; 35
IA Avramis (420_CR42) 2001; 21
SK Mungamuri (420_CR13) 2006; 66
T Palomero (420_CR11) 2007; 13
A Asada (420_CR29) 2000; 101
AP Weng (420_CR5) 2004; 306
HD Lewis (420_CR8) 2007; 14
P Sabbattini (420_CR35) 2005; 17
ML Sulis (420_CR6) 2008; 112
A Pazirandeh (420_CR26) 2000; 276
ML Deftos (420_CR32) 1998; 9
AP Weng (420_CR7) 2003; 23
E Anastasi (420_CR47) 2003; 171
D Bellavia (420_CR3) 2000; 19
IN King (420_CR33) 2006; 345
WS Pear (420_CR2) 1996; 183
C Talora (420_CR44) 2003; 4
V Fox (420_CR45) 2008; 26
D Bellavia (420_CR4) 2002; 99
HA Sikder (420_CR43) 2003; 3
T Palomero (420_CR10) 2006; 103
T Iso (420_CR15) 2001; 21
T Palomero (420_CR40) 2006; 20
DB Graham (420_CR28) 2006; 177
C Li (420_CR16) 2001; 98
P Baldi (420_CR18) 2001; 17
J van den Brandt (420_CR24) 2006; 36
AA Margolin (420_CR31) 2009; 106
T Nitta (420_CR36) 2006; 4
S Jarriault (420_CR14) 1995; 377
BM Bolstad (420_CR17) 2003; 19
MR Freeman (420_CR41) 1995; 55
HM Shin (420_CR12) 2006; 25
M Pandarpurkar (420_CR38) 2003; 100
AP Weng (420_CR9) 2006; 20
References_xml – volume: 25
  start-page: 129
  year: 2006
  ident: 420_CR12
  publication-title: Embo J
  doi: 10.1038/sj.emboj.7600902
  contributor:
    fullname: HM Shin
– volume: 35
  start-page: 3287
  year: 2005
  ident: 420_CR27
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200526279
  contributor:
    fullname: M Erlacher
– volume: 377
  start-page: 355
  year: 1995
  ident: 420_CR14
  publication-title: Nature
  doi: 10.1038/377355a0
  contributor:
    fullname: S Jarriault
– volume: 177
  start-page: 6098
  year: 2006
  ident: 420_CR28
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.9.6098
  contributor:
    fullname: DB Graham
– volume: 17
  start-page: 121
  year: 2005
  ident: 420_CR35
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2005.01.004
  contributor:
    fullname: P Sabbattini
– volume: 4
  start-page: 1067
  year: 2003
  ident: 420_CR44
  publication-title: EMBO Rep
  doi: 10.1038/sj.embor.7400013
  contributor:
    fullname: C Talora
– volume: 4
  start-page: e103
  year: 2006
  ident: 420_CR36
  publication-title: PLoS Biol
  doi: 10.1371/journal.pbio.0040103
  contributor:
    fullname: T Nitta
– volume: 19
  start-page: 3337
  year: 2000
  ident: 420_CR3
  publication-title: Embo J
  doi: 10.1093/emboj/19.13.3337
  contributor:
    fullname: D Bellavia
– volume: 276
  start-page: 189
  year: 2000
  ident: 420_CR26
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2000.3458
  contributor:
    fullname: A Pazirandeh
– volume: 281
  start-page: 5106
  year: 2006
  ident: 420_CR22
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M506108200
  contributor:
    fullname: CT Ong
– volume: 19
  start-page: 185
  year: 2003
  ident: 420_CR17
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/19.2.185
  contributor:
    fullname: BM Bolstad
– volume: 23
  start-page: 655
  year: 2003
  ident: 420_CR7
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.23.2.655-664.2003
  contributor:
    fullname: AP Weng
– volume: 6
  start-page: 152
  year: 2005
  ident: 420_CR46
  publication-title: Nat Immunol
  doi: 10.1038/ni1160
  contributor:
    fullname: X Tai
– volume: 166
  start-page: 3468
  year: 2001
  ident: 420_CR48
  publication-title: J Immunol
  doi: 10.4049/jimmunol.166.5.3468
  contributor:
    fullname: DJ McKean
– volume: 291
  start-page: 775
  year: 2002
  ident: 420_CR21
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2002.6528
  contributor:
    fullname: K Shimizu
– volume: 14
  start-page: 209
  year: 2007
  ident: 420_CR8
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2006.12.010
  contributor:
    fullname: HD Lewis
– volume: 183
  start-page: 2283
  year: 1996
  ident: 420_CR2
  publication-title: J Exp Med
  doi: 10.1084/jem.183.5.2283
  contributor:
    fullname: WS Pear
– volume: 26
  start-page: 8022
  year: 2006
  ident: 420_CR39
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01091-06
  contributor:
    fullname: VM Sharma
– volume: 3
  start-page: 525
  year: 2003
  ident: 420_CR43
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00141-7
  contributor:
    fullname: HA Sikder
– volume: 103
  start-page: 18261
  year: 2006
  ident: 420_CR10
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0606108103
  contributor:
    fullname: T Palomero
– volume: 306
  start-page: 269
  year: 2004
  ident: 420_CR5
  publication-title: Science
  doi: 10.1126/science.1102160
  contributor:
    fullname: AP Weng
– volume: 9
  start-page: 777
  year: 1998
  ident: 420_CR32
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80643-3
  contributor:
    fullname: ML Deftos
– volume: 20
  start-page: 2096
  year: 2006
  ident: 420_CR9
  publication-title: Genes Dev
  doi: 10.1101/gad.1450406
  contributor:
    fullname: AP Weng
– volume: 99
  start-page: 3788
  year: 2002
  ident: 420_CR4
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.062050599
  contributor:
    fullname: D Bellavia
– volume: 361
  start-page: 481
  year: 2007
  ident: 420_CR37
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2007.07.048
  contributor:
    fullname: M Keita
– volume: 66
  start-page: 4715
  year: 2006
  ident: 420_CR13
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3830
  contributor:
    fullname: SK Mungamuri
– volume: 345
  start-page: 446
  year: 2006
  ident: 420_CR33
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.04.097
  contributor:
    fullname: IN King
– volume: 101
  start-page: 309
  year: 2000
  ident: 420_CR29
  publication-title: Immunology
  doi: 10.1046/j.1365-2567.2000.00110.x
  contributor:
    fullname: A Asada
– volume: 198
  start-page: 299
  year: 1997
  ident: 420_CR20
  publication-title: Immunobiology
  doi: 10.1016/S0171-2985(97)80050-2
  contributor:
    fullname: LJ Strobl
– volume: 36
  start-page: 2223
  year: 2006
  ident: 420_CR24
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200535791
  contributor:
    fullname: J van den Brandt
– volume: 55
  start-page: 4140
  year: 1995
  ident: 420_CR41
  publication-title: Cancer Res
  contributor:
    fullname: MR Freeman
– volume: 4
  start-page: 336
  year: 2004
  ident: 420_CR25
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1349
  contributor:
    fullname: L Chen
– volume: 21
  start-page: 6071
  year: 2001
  ident: 420_CR15
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.21.17.6071-6079.2001
  contributor:
    fullname: T Iso
– volume: 106
  start-page: 244
  year: 2009
  ident: 420_CR31
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0806445106
  contributor:
    fullname: AA Margolin
– volume: 171
  start-page: 4504
  year: 2003
  ident: 420_CR47
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.9.4504
  contributor:
    fullname: E Anastasi
– volume: 26
  start-page: 715
  year: 2008
  ident: 420_CR45
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2007-0368
  contributor:
    fullname: V Fox
– volume: 13
  start-page: 1203
  year: 2007
  ident: 420_CR11
  publication-title: Nat Med
  doi: 10.1038/nm1636
  contributor:
    fullname: T Palomero
– volume: 18
  start-page: 7423
  year: 1998
  ident: 420_CR23
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.18.12.7423
  contributor:
    fullname: S Jarriault
– volume: 18
  start-page: 687
  year: 2004
  ident: 420_CR30
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2003-0390
  contributor:
    fullname: J van den Brandt
– volume: 298
  start-page: 840
  year: 2002
  ident: 420_CR34
  publication-title: Science
  doi: 10.1126/science.1074560
  contributor:
    fullname: H Hirata
– volume: 100
  start-page: 10382
  year: 2003
  ident: 420_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1832170100
  contributor:
    fullname: M Pandarpurkar
– volume: 20
  start-page: 1279
  year: 2006
  ident: 420_CR40
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404258
  contributor:
    fullname: T Palomero
– volume: 98
  start-page: 31
  year: 2001
  ident: 420_CR16
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.98.1.31
  contributor:
    fullname: C Li
– volume: 17
  start-page: 509
  year: 2001
  ident: 420_CR18
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/17.6.509
  contributor:
    fullname: P Baldi
– volume: 21
  start-page: 2281
  year: 2001
  ident: 420_CR42
  publication-title: Anticancer Res
  contributor:
    fullname: IA Avramis
– volume: 66
  start-page: 649
  year: 1991
  ident: 420_CR1
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90111-B
  contributor:
    fullname: LW Ellisen
– volume: 100
  start-page: 9440
  year: 2003
  ident: 420_CR19
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1530509100
  contributor:
    fullname: JD Storey
– volume: 112
  start-page: 733
  year: 2008
  ident: 420_CR6
  publication-title: Blood
  doi: 10.1182/blood-2007-12-130096
  contributor:
    fullname: ML Sulis
SSID ssj0017874
Score 2.1589448
Snippet Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level, Notch...
Abstract Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular...
Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level,...
BACKGROUNDDysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level,...
BACKGROUND: Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular level,...
Abstract Background Dysregulated Notch signalling is believed to play an important role in the development and maintenance of T cell leukaemia. At a cellular...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 35
SubjectTerms Apoptosis
Care and treatment
CD28 Antigens - genetics
CD28 Antigens - metabolism
Down-Regulation
Flow Cytometry
Gene Expression Profiling
Genetic aspects
GTP Phosphohydrolases - genetics
GTP Phosphohydrolases - metabolism
Health aspects
Humans
Inhibitor of Differentiation Protein 1 - genetics
Inhibitor of Differentiation Protein 1 - metabolism
Jurkat Cells
Leukemia, T-Cell - genetics
Leukemia, T-Cell - metabolism
Lymphocytic leukemia
Oligonucleotide Array Sequence Analysis
Receptors, Notch - genetics
Receptors, Notch - metabolism
Reproducibility of Results
Risk factors
Signal Transduction - genetics
T cells
Up-Regulation
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor A - metabolism
SummonAdditionalLinks – databaseName: BioMedCentral Open Access (Free Resource)
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMQFQXkFCviAxMkijscvDkgtoqqQ2lMrVVysxA9YdUkQ7CLx7xkn2bbuHjkm4zzsmbHnYX9DyNtQe5QEL5gWGhj4OmNAesWCSh3aI00UY2jg-EQdncGXc3l-Fe-4kcHnRr3noBUDaQ0zTMjb5E6TIc6zX37w9TJfgGI35o83bWd4xu3nb5xrXxbL0Yjavz03X1ucyo2T11aiw4fkwWxC0v2J54_IrdjvkrtTUcm_u-Te8Zwuf0w-Tsdw0xyXo0Oi_fAnLunJgMyi0y5w-i1Pd3TR01Oaw_h0GdcXbfyxaJ-Qs8PPp5-O2FwwgXVS21UO50HtJccrj3pmUgKIqY5oJYgY0DdpAdUXkggQOh9Vk9rWJmu4jgldPxBPyU4_9PE5oUnI1EGXpAgJOC5gXkdtJXjdNiYEUZEPxTi6nxM4hstw1SUFNcdlJrjMBGeckBV5txn0y-dGZ8SorZYHmSfF28cbKCFu1i0H3GfUs1bxGAElz3a6gQDKSyW4kB4_lznqssriH_l2PnmAPc3gV26_QZu5kThzVWSvaImq5gvym41MuEzK-9P6OKx_O5ULGxrOK_JskpCrfuUyu7q2FdGF7BRdKin94vuI890oa9A8fPE_Q_2S3J_yX4rVdo_srH6t4ys0o1bd61GD_gEoLRb9
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQpSIuqC2vlAI-IHGyGsfjVw-VCqKqkNpTK_VmJX7AiiVBsIvEv2ecZMtaPXDhGNtx4nl5xo9vCHkbao-S4AXTQgMDX2cMSK9YUKlDf6SJYlwauLxSFzfw6VbebqX6ymfCJnjgiXDHwH2GtGoVjxGwW9vpBgIoL5XgQvrR-nK5Cabm_QMUw3E_GbRiIK2Z4Rq5Ucd3ZcywnOStuOe-LKanEcX_vq3emqzKg5RbM9P5Hnk8u5T0bBrKPnkQ-wOyOyWZ_H1AHl7O2-dPyOl0LTfN63R0SLQffsUlvRqQeXQ6FU4_Z_NHFz29pnlZny7j-msbvy3ap-Tm_OP1hws2J1BgndR2lZf3oPaS45NHvTMpAcRUR_QaRAwYq7SA6gxJBAidj6pJbWuTNVzHhKEgiGdkpx_6-ILQJGTqoEtShAQcJzSvo7YSvG4bE4KoyElBR_d9AstwGb66rEFNcpkJLjPBGSdkRd5tiH733hicGHWv5fvMk6L3sQBFxs0i4_4lMvi5zFGXVRj_yLfzTQQcaQbDcmcN-tCNREtWkaOiJaqeL6rfbGTC5ap8Xq2Pw_qnUznRoeG8Is8nCfk7rpx2V9e2IrqQnWJIZU2_-DLifjfKGnQXD_8HDV6SR9O-mGK1PSI7qx_r-Ardq1X3etSkPx1oHYA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELagCNQLKuXRQAEfkDgF4nj8SCWKCqKqkLanrtSblTh2WbEksN1F9N93nLhsrYVj4kdizzf2jD3-TMibtrCIBMtzxRXkYIvAAWll3krfoD1SOj4sDUxO5ckUvp6L83X8U-zAy3-6duE-qeli_u7Pr6uPqPAfBoXX8j0DJXMQlc51zsVdcq8EDgHtE1jvKCAwIZI2bpYZqEPRVFEhLjE5-D5P5quB1n9z8L41e6WRlbemquMd8jDamPRoBMUjcsd1u-T-eOvk1S55MIn76Y_J4XhO18eFO9p72vW_3Zye9ihNOoaJ04swHtJZR89oWOenc7f6Xrsfs_oJmR5_Oft8kscbFfJGqGoZ1vugsILhk0VF1N4DOF84NCO4a9F5qQH1GzxvoW2sk6Wv68pXminn0TcE_pRsdX3n9gj1XPgGGi9464HhDGeVU5UAq-pSty3PyEHSj-bnyJ5hAp91moKqZYI8TJCH0YaLjLy96fS_5QZvRcuNnJ-CTJLahxf94sJE5TPAbKBFqyVzDhCaVaNKaEFaITnjwuLngkRNQBn-ka3j0QRsaWDHMkclGtWlQHhkZD_Jibpok-TXN5gwISkEsHWuX10aGW4-1Ixl5NmIkHW7IvAyohLsJE1KU7rZt4EIvJSVRvvx-X_rfEG2x90vmRfVPtlaLlbuJRpRy-bVoB3XgLUWqA
  priority: 102
  providerName: Scholars Portal
Title Identification of novel Notch target genes in T cell leukaemia
URI https://www.ncbi.nlm.nih.gov/pubmed/19508709
https://search.proquest.com/docview/67401811
http://dx.doi.org/10.1186/1476-4598-8-35
https://pubmed.ncbi.nlm.nih.gov/PMC2698846
https://doaj.org/article/41c6360a61ee44259b724d46c563135c
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtx8ZextZ9eesyPQz25Ca2Th_ewyApLSWQULoWwl6ELUttWGKXNinsv9_JH1tF3_ZiY8sfku53utPpdEfIl3JkEAmGxZJJiMGMfAxII-JSuAL1kdSyxjQwm4vTS5gu-GKH8H4vTOO0b4rlYbVaH1bL68a38mZthr2f2PBsdpSKTKHcHO6SXclYP0Xvlg4QgdBFZ0yUGCYgRQw8U7GKWZOnxuc9ld4BMdjhvgoEUxO___Eo_UBMhS6UD2TSyUvyolMm6bit9CuyY6t98rRNL_l7nzybdQvnr8n3dkOu6yx0tHa0qu_tis5rJBtt_cHplR_46LKiF9Qb9OnKbn_ldr3M35DLk-OLo9O4S50QF1xmG2_Yg5HhCV4Z5DjlHIB1I4v6ArMlzlJyQEYGx0ooC2NF6vI8c5lKpHU4CQT2luxVdWXfE-oYdwUUjrPSQYKizEgrMw5G5qkqSxaRb0E_6ps2TIb2gavDEuQh7emhPT200oxH5Gvf6X_fa6YlSjx6cuJpEny9uVHfXukOHBoS4-Of5SKxFhCDWSFTKEEYLljCuMHfeYpqz7xYI5N3exCwpT4Mlh6nqD2nHOERkYPgSWQ6ExR_7jGhfZH3VKtsvb3Twqc4VEkSkXctQv61qwNeRGSAnaBJYQkyQBPxuwP8h_9-8yN53i6DiXiUHZC9ze3WfkJtalMMkIcWckCejMfTH1M8T47nZ-eDxjaBxxkoPJ5Pfg4aLvsDAPIkjQ
link.rule.ids 108,230,315,733,786,790,870,891,2115,2236,24346,24965,27957,27958,31755,33780,53827,53829,76169,76170
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIh4XHqVAoFAfkDhlN45fCQekUlEt0F1x2KLerMSxy6q7SVV2keDXM84DanqC42aSbEbzjWdsj78BeFUlBpFgWKyY4jE3ieeANDKupCsxH0kta5cGpjM5OeEfT8XpFojhLExbtG_Kxaherkb14mtbW3mxMuOhTmz8eXqYyjzDuDm-ATfRX1M1TNL7zQPEIO_5GWkmx5QrGXORZ3EWs7ZTje98qnwJYnDGfRmEppbB__o4fSVQhUWUV6LS0X34MujTFaOcjzbrcmR-_kX1-M8KP4B7fZ5KDjrxQ9iy9Q7c6jpX_tiB29N-T_4RvO3O-rp-8Y80jtTNd7skswYRQbpSc3Lmx1SyqMmc-L0CsrSb88KuFsUunBy9nx9O4r4rQ1wKla_9miFPjKD4y6AzZ85xbl1iMRVhtsIJUMFxjOCOVbwqjZWpK4rc5RlV1uH8krPHsF03tX0KxDHhSl46wSrHKUZJo6zKBTeqSLOqYhG8CQykLzoGDu05sUMJuqf2htbe0DrTTETwerDm7-faGU8mr935zhs7eHt7obk8070ZNKfGU6sVklrLEd55qVJecWmEZJQJg3_noaL9uIBfZIr-eANq6hm29EGKiXkqEHcR7AV3oj-bQLw_gE17kS-Cq22z-aal756YURrBkw56f_TqER2BCkAZqBRKEGotmXgPrWf__eQ-3JnMp8f6-MPs03O42-22yTjJ92B7fbmxLzBpW5cvWxf9BdL-P6U
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagiIpLgUIhUKgPSJyyefgZDkilsCqPXfXQShUXK3Hssupusmp3keDXM04cWNNbj4mdx2i-8Yzt8TcIvalTDUjQJBZE0Jjq1HFAah7X3FYQj-SGdEsDkyk_PqNfztn5RqmvLmlfV7NRM1-MmtmPLrdyudDJkCeWnEyOcl5I8JvJsrbJXXQPbDYvhom630AAHFLP0ZhJnmRU8JiyQsYyJl21Glf9VLg0xOCc-zxwTx2L_82xesNZhYmUG55p_BB9H2TqE1IuR-tVNdK__6N7vJXQj9COj1fxYd_lMbpjml10v69g-WsXbU_83vwT9L4_82v9IiBuLW7an2aOpy0gA_cp5_jCja141uBT7PYM8NysL0uzmJVP0dn40-nRceyrM8QVE8XKrR3SVLMMrjQYtbSWUmNTAyEJMTVMhEoKYwW1pKZ1pQ3PbVkWtpCZMBbmmZTsoa2mbcxzhC1htqKVZaS2NANvqYURBaNalLmsaxKhd4GS1LJn4lCOGztsATNVTtnKKVtJRViE3g4a_ftcN_OR_EbPD07hwdu7G-3VhfKqUDTTjmKt5JkxFGBeVCKnNeWacZIRpuFzDi7KjQ_wR7r0xxxAUse0pQ5zCNBzBtiL0H7QE-xaB80HA-CUa3LJcI1p19eKuyqKMssi9KyH3z-5PKojJAJgBiKFLQC3jlTcw-vFrZ88QNsnH8fq2-fp15foQb_pxuO02Edbq6u1eQWx26p63VnpH80vQiU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+novel+Notch+target+genes+in+T+cell+leukaemia&rft.jtitle=Molecular+cancer&rft.au=Chadwick%2C+Nicholas&rft.au=Zeef%2C+Leo&rft.au=Portillo%2C+Virginia&rft.au=Fennessy%2C+Carl&rft.date=2009-06-09&rft.eissn=1476-4598&rft.volume=8&rft.spage=35&rft_id=info:doi/10.1186%2F1476-4598-8-35&rft_id=info%3Apmid%2F19508709&rft.externalDocID=19508709
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon